Member Info for Howzaty

Too much wine but you get my drift ...

Toxicity of the substrate was a concern I had, dox is not an issue at all, but in the interims AS suggested toxicity of the substrate has all but ellimated through an8mal testing, so once again the tox risk is much reduced.

Agreed PL and lets not forget the "significant pipeline" of other LFT products waiting to be brought to market.

Getting the fact that knowing an individual is not infectious is more important than knowing that they have been double vaccinated into the media and to our MPs at every opportunity is key for me. So my suggestion is that we should all do so whenever the opportunity arises emphasising that 'normal life' is unlikely to resume until a testing-certificate/ passport concept is established utilising only the best high quality tests.

Just running a few things through my mind. Today it was stated that a lot of "work was done in animals and so on to exclude toxicity of the substrate", this had been my biggest concern, we also heard that Al is "very pleased with progress", we have heard previously that "binding to FAP alpha is exquisite" and of course doxorubicin is a very well known and well used chemo drug. So can anyone explain why the share price is not sat at 800p. Seems odd to me is all Im saying. Perhaps next week, or so.

Todays share price action, as someone said on another board, is laughable. No rightminded person would be selling today. It is blatant share price manipulation and I cant wait for the manipulators to get there comeuppance, hopefully we dont have long to wait.

Only once before have I heard the phrase "I am very pleased" voiced with such genuine pleasure and excitement and that resulted in what is probably the best Covid LFT in the world (how about that for an advertising campaign) now its being said about AVA 6000, I feel I know whats coming and its huge. Hold for Gold.

Russell, thats as maybe but I'd like to take the opportunity to say its been a great pleasure hearing from you from time to time just in case. Thanks again.

Mikey, what about sharing a few of your hot tips?

"shouldnt really be here", better to say if you're here for less than a 500p youre being a bit short sighted to say the least since many will wait for 2500, perhaps with a little top slicing!

Whats often not discussed regarding large salaries funded by the taxpayer is that the recipients often take early retirement on something approaching two thirds final salary and recruitment starts over again. Its a fallacy to suggest that positions wouldnt be filled by talented people if lesser salaries were offered. There are plenty of talented folk who don't have the benefit of private education, but then where would the likes of Giles and Sophia and their ilk work and how would they afford their Range Rovers. You know what as a life long Conservative I may actually vote Labour next time around.

Heard on Radio 4 News this morning that the NHS is struggling with the cost of Chemotherapy for advanced Cancer patients. Wouldnt it be helpful if Chemo drugs could target tumours very precisely so that none of the chemo drug escapes the tumour and treatment could be reduced. Enter AVA 6000 ...

The phrase "Its not about demand its about supply" comes to mind, now where did I hear that ....

"Lost all Confidence " - I make it a point not to recommend buying or selling anymore since everyones situation is different, but what I would say is that when and if this tanker turns on good news in respect of LFTs and AVA6000 in the next weeks it will likely shoot through +50% without pausing for breath then on to 600p or more in short order. Against that on bad news it could go down say 40% and stay between that and 100p ish for some months to perhaps a year before some of the less talked about prospects start to deliver. All in my own opinion of course and no guarantees but read MMs 'Aim Chaos' if you want some depth. Not reading bulletin boards might be a good idea until news lands. I hope that helps.

Just to say the LFT business that has been established over the last 12 months is bigger than Covid and to a degree underwrites the share price. Point Biopharma's engagement with Affimers is growing and underwrites the share price to a degree, BAMS has not died, ELISA tests are being sold. Affimers themselves are worth a fortune and continue to be marketed in a world where Antibodies developed in animals are to be phased out. In my own opinion there are plenty of opportunities to regain the 280p if all else goes tits up and 2500p disappears over the horizon.

For cruise liners in particular stating that fellow passengers will be tested and confirmed Covid free with an easy painless and high accuracy LFT s a huge selling point. Why Airlines would hesitate to offer the same defies logic in my opinion.

Bella "No but ..." , one has to wonder why the whole focus of the enterprise wouldnt be on Affimers from the outset given that the EU is calling for Antibody use to be phased out in coming years and given the cost and stability benefits Affimers offer.

What many investors seem not to recognise (still) is that massive sales of the AffiDX is not essential to Avactas success. Avacta has built a Diagnostics business over the last twelve months, which is itself worth many millions and which Global Pharma is well aware of and watching closely. If AffiDx earns a few tens of millions thats more than enough to avoid future cash calls, so job done. AVA 6000 and everything else is what will, for the most part, yield a share price north of 2500p. Patience is all and if AffiDX does earn large then so much the better.

May be 113 potential suppliers but one test is more accurate than all the others and very easy to perform. So sales will likely favour Avacta. Good times are a coming.

"Not saying poor appointments" Als assessment is "three world leading oncologists" bit of a gap there!